HDAC6 as privileged target in drug discovery: A perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HDAC6 as privileged target in drug discovery: A perspective

Published:2021-01 Issue: Volume:163 Page:105274
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Pulya Sravani,Amin Sk. Abdul,Adhikari Nilanjan,Biswas Swati,Jha Tarun,Ghosh Balaram

Funder

Department of Science and Technology, Ministry of Science and Technology, India

Council of Scientific and Industrial Research, India

Publisher

Elsevier BV

Subject

Pharmacology

Reference200 articles.

1. Genetic syndromes caused by mutations in epigenetic genes;Berdasco;Hum. Genet.,2013

2. The role of epigenetics in personalized medicine: challenges and opportunities;Rasool;BMC Medical Genomics.,2015

3. Translating the histone code;Jenuwein;Science.,2001

4. Crystal structure of the nucleosome core particle at 2.8 Å resolution;Luger;Nature.,1997

5. Chromatin Structure: A Repeating Unit of Histones and DNA;Kornberg;Science.,1974

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin A;European Journal of Pharmaceutical Sciences;2024-10

2. Inhibiting histone deacetylase 6 suppresses the proliferation of microvascular endothelial cells by epigenetically activating miR-375-3p, potentially contributing to bone loss during mechanical unloading;Journal of Translational Medicine;2024-09-02

3. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment;European Journal of Medicinal Chemistry;2024-09

4. Design, synthesis, and evaluation of a novel TRAIL-activated HDAC6 inhibitor for the treatment of pulmonary fibrosis;Bioorganic & Medicinal Chemistry;2024-09

5. Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer;Nature Cancer;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3